CORC  > 暨南大学
MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF
Li, B.[1,2,3,10]; Xu, W. W.[1,2,11]; Han, L.[1,2]; Chan, K. T.[4]; Tsao, S. W.[1,3]; Lee, N. P. Y.[3,4]; Law, S.[3,4]; Xu, L. Y.[5]; Li, E. M.[5]; Chan, K. W.[3,6]
2017
卷号36期号:[db:dc_citation_issue]页码:3986
DOI[db:dc_identifier_doi]
URL标识查看原文
WOS记录号[DB:DC_IDENTIFIER_WOSID]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3330452
专题暨南大学
作者单位1.[1]Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China
2.[2]Univ Hong Kong, Shenzhen Inst Res & Innovat HKU SIRI, Shenzhen, Peoples R China
3.[3]Univ Hong Kong, Ctr Canc Res, Pokfulam, Peoples R China
4.[4]Univ Hong Kong, Dept Surg, Pokfulam, Peoples R China
5.[5]Shantou Univ Med Coll, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou, Peoples R China
6.[6]Univ Hong Kong, Dept Pathol, Pokfulam, Peoples R China
7.[7]Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Oncol, Zhengzhou, Peoples R China
8.[8]Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Pokfulam, Peoples R China
9.[9]Jinan Univ, Coll Life Sci & Technol, 601 West Huangpu Blvd, Guangzhou, Guangdong, Peoples R China
10.[10]Jinan Univ, Coll Life Sci & Technol, 601 West Huangpu Blvd, Guangzhou 510632, Guangdong, Peoples R China
推荐引用方式
GB/T 7714
Li, B.[1,2,3,10],Xu, W. W.[1,2,11],Han, L.[1,2],et al. MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF[J],2017,36([db:dc_citation_issue]):3986.
APA Li, B.[1,2,3,10].,Xu, W. W.[1,2,11].,Han, L.[1,2].,Chan, K. T.[4].,Tsao, S. W.[1,3].,...&Cheung, A. L. M.[1,2,3].(2017).MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.,36([db:dc_citation_issue]),3986.
MLA Li, B.[1,2,3,10],et al."MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF".36.[db:dc_citation_issue](2017):3986.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace